Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial

Authors

Institutions

Publication Details

Journal
BMC Medicine
Published
2026-03-03
DOI
https://doi.org/10.1186/s12916-026-04758-3
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial

Kaiyi Fu, Lung‐Chun Lin, Shiman Fu, Beibei Mao et al.
BMC Medicine
Esophageal Cancer Research and Treatment
article

Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial

Kaiyi Fu, Lung‐Chun Lin, Shiman Fu, Beibei Mao, W. Li, G. Chen, Shenyang Zhao, Hongyang Zhang, Zhiqiang Chen, Yang Song, Bin Lv, Jianxing Liu, Xia Guo, Wanwei Zheng, Ning Wu, Zhongguang Luo, Feifei Luo, Shaocong Mo, Yongjun Zhu, Jiayan Wu, Feng Tang, Jun Zhang, Yumeng Guo, Yao Liu, Kewei Ma, Yujen Tseng
article en

Abstract

No abstract available for this paper.
BMC Medicine
Fudan University (CN), Huashan Hospital (CN), Genecast (China) (CN)
Good health and well-being
Openalex Percentile: Top 35%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.